Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan

AIMS: To assess cardiac safety in COVID-19 patients treated with the combination of Hydroxychloroquine and Azithromycin using arrhythmia risk management plan. METHODS AND RESULTS: We retrospectively examined arrhythmia safety of treatment with Hydroxychloroquine and Azithromycin in the setting of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Maneikis, Kazimieras, Ringeleviciute, Ugne, Bacevicius, Justinas, Dieninyte-Misiune, Egle, Burokaite, Emilija, Kazbaraite, Gintare, Monika Janusaite, Marta, Dapkeviciute, Austeja, Zucenka, Andrius, Peceliunas, Valdas, Kryzauskaite, Lina, Kasiulevicius, Vytautas, Ringaitiene, Donata, Zablockiene, Birute, Zvirblis, Tadas, Marinskis, Germanas, Jancoriene, Ligita, Griskevicius, Laimonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734220/
https://www.ncbi.nlm.nih.gov/pubmed/33335973
http://dx.doi.org/10.1016/j.ijcha.2020.100685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734220/
https://www.ncbi.nlm.nih.gov/pubmed/33335973
http://dx.doi.org/10.1016/j.ijcha.2020.100685

Ejemplares similares